364 related articles for article (PubMed ID: 17881206)
1. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes).
Dal Negro RW; Tognella S; Tosatto R; Dionisi M; Turco P; Donner CF
Respir Med; 2008 Jan; 102(1):92-101. PubMed ID: 17881206
[TBL] [Abstract][Full Text] [Related]
2. Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study.
Dal Negro RW; Micheletto C; Tosatto R; Dionisi M; Turco P; Donner CF
Respir Med; 2007 Dec; 101(12):2511-9. PubMed ID: 17822890
[TBL] [Abstract][Full Text] [Related]
3. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Chiang CH
Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
[TBL] [Abstract][Full Text] [Related]
4. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
5. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
6. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
[TBL] [Abstract][Full Text] [Related]
8. Healthcare costs of COPD in Italian referral centres: a prospective study.
Koleva D; Motterlini N; Banfi P; Garattini L;
Respir Med; 2007 Nov; 101(11):2312-20. PubMed ID: 17681461
[TBL] [Abstract][Full Text] [Related]
9. The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.
Bilde L; Rud Svenning A; Dollerup J; Baekke Borgeskov H; Lange P
Respir Med; 2007 Mar; 101(3):539-46. PubMed ID: 16889949
[TBL] [Abstract][Full Text] [Related]
10. Predicting the costs of managing patients with chronic obstructive pulmonary disease.
Mapel DW; McMillan GP; Frost FJ; Hurley JS; Picchi MA; Lydick E; Spencer MD
Respir Med; 2005 Oct; 99(10):1325-33. PubMed ID: 16140232
[TBL] [Abstract][Full Text] [Related]
11. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
Akazawa M; Biddle AK; Stearns SC
Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
[TBL] [Abstract][Full Text] [Related]
12. COPD: illness severity, resource utilisation and cost.
Tynan AJ; Lane SJ
Ir Med J; 2005 Feb; 98(2):41-2, 44-5. PubMed ID: 15835510
[TBL] [Abstract][Full Text] [Related]
13. Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease.
Gallefoss F; Bakke PS
Respir Med; 2000 Mar; 94(3):279-87. PubMed ID: 10783940
[TBL] [Abstract][Full Text] [Related]
14. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
[TBL] [Abstract][Full Text] [Related]
15. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
Jahnz-Rózyk K; Targowski T; From S; Płusa T
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
[TBL] [Abstract][Full Text] [Related]
16. The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial.
Gallefoss F
Patient Educ Couns; 2004 Mar; 52(3):259-66. PubMed ID: 14998595
[TBL] [Abstract][Full Text] [Related]
17. Retrospective incremental cost analysis of a hospital-based COPD Disease Management Programme in Sweden.
Tunsäter A; Moutakis M; Borg S; Persson U; Strömberg L; Nielsen AL
Health Policy; 2007 May; 81(2-3):309-19. PubMed ID: 16904788
[TBL] [Abstract][Full Text] [Related]
18. Cost impact of COPD in Japan: opportunities and challenges?
Nishimura S; Zaher C
Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of chronic obstructive pulmonary disease.
Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
[TBL] [Abstract][Full Text] [Related]
20. An integrated care facilitation model improves quality of life and reduces use of hospital resources by patients with chronic obstructive pulmonary disease and chronic heart failure.
Bird S; Noronha M; Sinnott H
Aust J Prim Health; 2010; 16(4):326-33. PubMed ID: 21138701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
